The company, Accelerated Evolution Biotechnologies Ltd. (AEBi), has described its treatment, MuTaTo, as comparable to a cancer antibiotic that uses a multipronged approach similar to the treatment given to HIV patients. The Israeli team told The Jerusalem Post that this treatment relies on a combination of several peptides for each cancer cell, reportedly eliminating the chances of evasion through mutation.
“We believe we will offer in a year’s time a complete cure for cancer,” Dan Aridor, of AEBi, told the news outlet.
The company’s CEO, Dr. Ilan Morad, said MuTaTo also works to target cancer stem cells, eliminating the chances of recurrence, with Aridor claiming that it will be effective from “Day 1” and cause “no or minimal side effects at a much lower cost than most other treatments.”
“Our solution will be both generic and personal,” Aridor said.
But at least one expert in the U.S. has questioned the potential cure’s legitimacy and said it’s more likely just another claim on a list of “irresponsible and ultimately cruel false promises” for cancer patients.
But Dr. Ben Neel, director of Perlmutter Cancer Center at NYU Langone Health, is skeptical, telling Fox News via email: “Of course, curing cancer is the goal of everyone who comes to work every day at a cancer center — and if this company does, in fact, cure cancer, they will have my congratulations and thanks. But cancer is multiple diseases, and it is highly unlikely that this company has found a ‘cure’ for cancer, anymore than there is a single cure for infections.”
The treatment has not been tested in humans yet, although Aridor said it has shown success in mice and is nearing the clinical trial stage.
Said Neel, “More likely, this claim is yet another in a long line of spurious, irresponsible and ultimately cruel false promises for cancer patients.”
More detail from the Daily Wire’s post:
Morad said the company’s initial efforts involved attempting to find “individual novel peptides for specific cancers.” But then he and colleague Dr. Hanan Itzhaki decided to go for broke. He explained that most anti-cancer drugs attack a specific target on or in the cancer cell, but they often trigger a mutation that makes the drug ineffective. But MuTato, as the Jerusalem Post notes, uses “a combination of several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells specifically.”
Morad said MuTato, because it attacks multiple targets, destroys the proteins targeted on the cancer cell. Morad also said because the peptide parts of MuTaTo are tiny and flexible, they can penetrate areas other drugs fail to reach. He stated, “This should make the whole molecule non-immunogenic in most cases and would enable repeated administration of the drug.”
Dr Ben Neel is big on research and biology as well as being the recipient of numerous government grants, so of course he’d dismiss it. Many people, including me, have long believed that there’s more money to be made in research and treatment than there is curing it and that’s part of the reason we haven’t found a cure.
Dr. Manny Alvarez on Fox said that over the last 25 years cancer deaths have declined 27%, due to better screenings and treatments. Any decline is good, but that’s barely more than one percent per year. With all the money we pour into this horrible disease, we should be doing better.
There’s probably not a person in this country that either hasn’t had cancer or at least been affected by it, so this is the best news we’ve seen in a very long time. Leave it to the Israelis, untethered by multitudes of US government regulations, to find a different approach and come away with a possible cure.